San Antonio, TX, United States of America

Cara B Gonzales

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 1.5

ph-index = 1


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Cara B Gonzales

Introduction

Cara B Gonzales is a notable inventor based in San Antonio, TX (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of new compounds. With a total of 3 patents, her work focuses on the therapeutic potential of capsazepine analogs.

Latest Patents

Gonzales' latest patents include groundbreaking work on capsazepine analogs for the treatment of cancer and other proliferative diseases. The present disclosure relates to derivatives of capsazepine and methods of use thereof. In some aspects, the present disclosure relates to using capsazepine derivatives to treat cancer or other hyperproliferative diseases. The compounds may be useful in treating various cancers, including but not limited to breast, cervical, oral, head, neck, or prostate cancer. In some aspects, the compounds may be administered through direct injection into the tumor, particularly in cases of oral tumors. Additionally, the compounds can be administered systemically and may also help alleviate pain associated with tumors.

Career Highlights

Cara B Gonzales is affiliated with the University of Texas System, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer treatment and patient care.

Collaborations

Gonzales has collaborated with notable colleagues, including Stanton F McHardy and Stanton Mchardy, to advance her research initiatives.

Conclusion

Cara B Gonzales is a pioneering inventor whose work in developing capsazepine analogs holds promise for improving cancer treatment. Her contributions to the field are significant and reflect her dedication to innovation in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…